Our News
Introducing Menu Based Conjoint To The IDR Medical Service Portfolio
Menu Based Conjoint (MBC) is designed to maximise revenue for complex products and services where customers can choose feature sets at specific price points from a menu of available options. This approach enables companies to develop optimal product and price packages, for example where they provide a base product to which optional features can be added or where feature bundles can be offered to generate the greatest return on investment.
Strategies In Response to Low Cost Medical Device Vendors
Driven by the global squeeze on healthcare expenditure, low cost vendors are making significant in-roads on maturing med-tech markets. Over recent years medical device brands previously dismissed as low quality by hospital decision makers are not only making regular appearances on hospital tenders but are winning those tenders. A select group of low cost vendors are convincing users and decision makers that the “quality” of their product and service is comparable to that of the premium brand. While users may be reluctant to switch they often find themselves lacking a convincing argument to justify the additional expense of a premium and often incumbent brand.
IDR Medical Welcomes James Fox to the Consulting Tea
IDR Medical is pleased to announce that James Fox has joined our Global team as a Senior Consultant.
IDR Medical KOL's Provide Insight on Clinical Trial Design & Optimisation For Medical Technology
An improved trial design offers a wide range of opportunity for better science, better ethics and better R&D investment. IDR Medical have been involved in a number of studies to advise clients on clinical trial design for medical devices and technology.
Pricing Strategy Continues to be a Core Focus for IDR Medical
The key to success for our pricing projects is designing a methodology which realistically predicts the market response at a range of price points.
IDR Medical Welcomes Dr. Vangelis Papagrigoriou To the Consulting Team
IDR Medical is pleased to announce that Vangelis Papagrigoriou has joined our global team as a European Consultant.
IDR Medical Develops Economic Cost Benefit Models For New Medical Devices
In recent months IDR Medical have been involved in a number of projects to understand price sensitivities in context of the economic cost/benefit a particular device or technology can present to a customer.
IDR Medical Attending ESC Congress in Paris 27th - 31st August 2011
IDR Medical will be attending the ESC Congress in Paris on the 27th August 2011. To meet with one of our consultants please send an email entitled ESC Paris to info@idrmedical.com
IDR Medical Develops Market Expertise in Regenerative Medicine
Regenerative medicine is an emerging interdisciplinary field of research and clinical applications focused on the repair, replacement or regeneration of cells, tissues, bones or organs.
